
The changes have sparked anxiety among patients who depend on public health insurance to access expensive cancer medication, chemotherapy and essential diagnostic services.
According to reports from healthcare providers, the new approval system has introduced additional administrative procedures, requiring oncology treatment requests to pass through several approval stages before patients can access their medication and treatment.
At Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH), only 12 out of 30 oncology treatment requests submitted to SHA on Monday were approved, raising concerns about delays in accessing essential cancer care.
Even some patients whose requests were approved reportedly had to pay additional amounts from their pockets before receiving treatment.
One particularly concerning case involved a patient whose medication allocation was reportedly reduced to Sh5,400, despite requiring more than Sh20,000 for monthly medication.
Healthcare workers have also raised concerns about growing queues at oncology clinics as patients wait for multiple approvals before proceeding with scheduled treatment.
Cancer patient representatives are questioning why changes to the healthcare financing system are creating additional financial and administrative challenges for people already facing difficult medical circumstances.
The Kenya Network for Cancer Organisations (KENCO) has called for greater transparency and clarification regarding the new approval procedures, treatment limits and restrictions affecting access to cancer medication.
SHA RESPONDS TO THE CONCERNS
SHA maintains that the changes are intended to improve cancer care by aligning treatment with national cancer treatment guidelines, standardising medicine prices and ensuring better utilisation of available resources.
The authority says the enhanced oncology benefit package provides up to KSh 800,000, comprising KSh 400,000 under the Social Health Insurance Fund (SHIF) and another KSh 400,000 under the Emergency, Chronic and Critical Illness Fund, subject to eligibility and applicable benefit conditions.
SHA has also stated that patients should not be charged again for services already covered and paid for under the approved benefits package.
QUESTIONS THAT NEED URGENT ANSWERS
The situation raises important questions about the implementation of Kenya's healthcare financing reforms:
Why are patients experiencing delays in accessing essential cancer treatment?
Are the new approval procedures improving efficiency or creating additional barriers?
How will patients who cannot afford unexpected top-up payments continue their treatment?
How will SHA ensure that approved benefits translate into timely access to medication and diagnostic services?
Cancer treatment requires consistency, timely intervention and financial protection. Administrative reforms should strengthen access to healthcare rather than create uncertainty for patients.
The government and SHA must urgently address the concerns raised by patients, healthcare providers and cancer organisations to ensure that no patient is left without essential treatment because of administrative delays or unexpected financial barriers.